Ulrike Haug

Prof. Dr. sc. hum.
Leibniz Institute for Prevention Research and Epidemiology - BIPS, Germany

Poster(s):

• (8) Brodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) Study of a Biological Anti-Psoriatic Drug Across Six European Countries
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (S) Use of Methotrexate in Girls and Women of Childbearing Age and Occurrence of Methotrexate-Exposed Pregnancies in Germany
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (U) Outpatient Antibiotic Prescribing in Early Life: A Population-Based Study Comparing Birth Cohorts from Denmark and Germany
  Sunday, August 28, 2022

  8:00 AM – 6:00 PM CEST

• (19) Estimating Incidence and Case Fatality of Thyroid Storm in Germany Between 2007 and 2017: A Claims Data Analysis
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (166) MINERVA: Metadata for Data Discoverability and Study Replicability in Observational Studies
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (91) Time Trends in Antidepressant Use Among Women Aged 45-75 in Germany
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (227) Treatment with Tumor Necrosis Factor Alpha Inhibitors During Pregnancy and Occurrence of Severe Infections Among Infants: A Descriptive Analysis Based on German Claims Data
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (213) Use of Isotretinoin Among Girls and Women of Childbearing Age and Exposure During Pregnancy
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (226) Use of Rivaroxaban During Pregnancy and Description of Pregnancy Outcomes
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (109) Use of Fingolimod and Teriflunomide in Women of Childbearing Age and During Pregnancy in Germany
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST